[LS-32] Luncheon Seminar 32 Treatment of Parkinson's Disease

[LS-32-1] Optimal use of MAO-B inhibitors in clinical practice　～the current and future landscape of Safinamide～

^○Yoshio Tsuboi (Department of Neurology, Fukuoka University)